Pfizer seeks emergency approval for Corona Vaccine in India

New Delhi: Corona virus vaccine vaccination has begun in Moscow. With which this is also good news for India. The Indian unit of the pharmaceutical company Pfizer has applied to the Controller General of Indian Drugs (DCGI). For formal approval of the emergency use of the Covid-19 vaccine developed by it.

Permissions for vaccines

If the news is to be believed, in its application filed to the drug regulator, the company has requested for approval regarding the import and distribution of vaccines in the country.

Apart from this, under the special provisions of the Drugs and Clinical Trials Rules, 2019, the population of India also requested to exempt from clinical trials.

ALSO READ: Joe Biden says ‘We are ready to get Covid-19 Vaccine’

Pfizer India has applied to the DGCI on 4 December for approval of emergency use of covid 19 vaccine in India.

On Wednesday, Britain was granted temporary approval of Pfizer's Covid-19 vaccine for emergency Pfizer. After this, Bahrain became the second country in the world on Friday to formally approve the emergency use of the Covid-19 vaccine developed by pharmaceutical manufacturer Pfizer and its German partner Bioentech.

Let me tell you, it is necessary to keep this Pfizer vaccine at minus 70 ° C. Due to which India can face many situations. Clinical trials of vaccines also not organised in India yet.

ALSO READ: Public health will be top priority as far as vaccine pricing is concerned- Modi

Prime Minister Narendra Modi said on Friday, ‘Around 8 vaccine trials are going on. For which the production promised in India. There are 3 vaccines in India at different stages. Experts believe that the vaccine is not far away. ‘ India has entered into a deal with Oxford AstraZeneca, a vaccine tester at the Serum Institute, in Pune, and most vaccine doses are available here.

Stay tuned with the newstrack to get fastest updates. Click @englishnewstrack to follow us on Facebook and @newstrackmedia to follow on Twitter.